Clariant has released its financials for the first half of 2018.
The company saw sales grow 7% in local currency to CHF 3.389 billion. Growth was supported by contributions from all divisions, particularly catalysis and care chemicals.
Sales in care chemicals grew 9% in the first half of 2018, with both consumer care and industrial applications delivering “robust growth.” During the second quarter specifically, sales grew 10% supported primarily by consumer care and industrial applications. Highlights included Genadvance, a new range of hair conditioning ingredients which debuted at in-cosmetics Global 2018 in Amsterdam.
“In the first half of the year, Clariant delivers strong growth in sales, EBITDA and most notably net income,” said CEO Hariolf Kottmann. “Our adherence to Clariant’s five-pillar strategy has resulted in the steady progress we have seen over the last years. We continue to focus on innovation and sustainability for portfolio advancement, leading to further progress in growth and profitability. For 2018, I am confident that we will achieve our targets.”